GGrantIndex
← Leaderboards

Raina N Fichorova

New York Blood Center

$12,015,561
Attributed
$14,926,874
Total exposure
9
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY200725
$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$14,926,874 · 9

By mechanism

R01$12,646,495 · 4
R56$876,546 · 1
RC1$498,935 · 1
R41$454,968 · 1
R21$449,930 · 1
P01$0 · 1

Top collaborators

Others in their field

Top investigators on “Woman

Research focus

WomanRisk FactorsInflammationLaboratoriesSamplingIncidenceMolecularImmuneImmunityPathway InteractionsTransmission ProcessHiv InfectionsVaginaPredispositionCervicalHiv-1Natural ImmunityAffectComplexMucous MembraneGenital SystemPregnancyInfectionReproductive

Grant awards (27)

Molecular Antecedents of Miscarriage$740,209
R01 · FY2025 · HD · contact PI
Molecular Antecedents of Miscarriage$733,193
R01 · FY2024 · HD · contact PI
MicroRNA Predictors of HIV Risk in Reproductive Age Women$789,436
R01 · FY2023 · HD · contact PI
Molecular Antecedents of Miscarriage$740,868
R01 · FY2023 · HD · contact PI
MicroRNA Predictors of HIV Risk in Reproductive Age Women$800,965
R01 · FY2022 · HD · contact PI
Molecular Antecedents of Miscarriage$760,527
R01 · FY2022 · HD · contact PI
Cervical Cancer Prevention Prebiotic Device$54,975
R41 · FY2022 · CA
MicroRNA Predictors of HIV Risk in Reproductive Age Women$812,249
R01 · FY2021 · HD · contact PI
Cervical Cancer Prevention Prebiotic Device$399,993
R41 · FY2021 · CA
MicroRNA Predictors of HIV Risk in Reproductive Age Women$820,132
R01 · FY2020 · HD · contact PI
MicroRNAs as regulators of drug metabolism and transport in pregnant and lactating women$168,814
R01 · FY2020 · HD · contact PI
MicroRNA Predictors of HIV Risk in Reproductive Age Women$883,063
R01 · FY2019 · HD · contact PI
Innate immunity predictors of HIV: the role of contraception, pregnancy and HSV-2$434,605
R01 · FY2017 · HD
Innate immunity predictors of HIV: the role of contraception, pregnancy and HSV-2$455,489
R01 · FY2016 · HD
Innate immunity predictors of HIV: the role of contraception, pregnancy and HSV-2$484,828
R01 · FY2015 · HD
Innate immunity predictors of HIV: the role of contraception, pregnancy and HSV-2$503,255
R01 · FY2014 · HD
Innate immunity predictors of HIV: the role of contraception, pregnancy and HSV-2$514,684
R01 · FY2013 · HD
T. vaginalis viruses as mucosal immunity modifiers with impact on women's health$876,546
R56 · FY2012 · AI · contact PI
Molecular T. vaginalis-host interactions in relevance to inflammatory sequelae$736,268
R01 · FY2012 · AI · contact PI
Molecular T. vaginalis-host interactions in relevance to inflammatory sequelae$750,131
R01 · FY2011 · AI · contact PI
Molecular T. vaginalis-host interactions in relevance to inflammatory sequelae$765,263
R01 · FY2010 · AI · contact PI
T. vaginalis viruses as mucosal immunity modifiers with impact on women's health$498,935
RC1 · FY2010 · AI · contact PI
Molecular T. vaginalis-host interactions in relevance to inflammatory sequelae$752,516
R01 · FY2009 · AI · contact PI
Trichomonas Lipophosphoglycan in Regulation Immune Responses$162,680
R21 · FY2008 · HD · contact PI
Trichomonas Lipophosphoglycan in Regulation Immune Responses$287,250
R21 · FY2007 · HD · contact PI
ANTI-HIV1 MICROBICIDES$0
P01 · FY2002 · HD
ANTI-HIV1 MICROBICIDES$0
P01 · FY2001 · HD